Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1993;22:743-753

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lipke, D. W.
Right arrow Articles by Couchman, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lipke, D. W.
Right arrow Articles by Couchman, J. R.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure

Hypertension, Vol 22, 743-753, Copyright © 1993 by American Heart Association


ARTICLES

Coarctation induces alterations in basement membranes in the cardiovascular system

DW Lipke, KJ McCarthy, TS Elton, SS Arcot, S Oparil and JR Couchman
Vascular Biology and Hypertension Program, University of Alabama at Birmingham.

A coarctation hypertensive rat model was used to examine the effects of elevated blood pressure on basement membrane component synthesis by cardiac myocytes and aorta using immunohistochemistry and Northern blot analysis. Carotid arterial pressure increased immediately on coarctation, and left ventricular hypertrophy was maximal within 5 days. In immunohistochemical studies, fibronectin and laminin were increased and the basement membrane chondroitin sulfate proteoglycan decreased in both the subendothelial space and smooth muscle cell basement membranes of the aorta above the clip compared with controls, whereas only fibronectin was elevated in the aorta below the clip. No change in basement membrane staining intensity for the cardiac myocytes was observed. Alterations in steady-state mRNA levels for fibronectin and laminin in the aorta paralleled those observed by immunohistochemical analysis with regard to protein and tissue type affected as well as intensity of the changes. However, changes in mRNA levels (but not protein deposition) for perlecan and type IV collagen were also observed in aortas from hypertensive rats compared with controls. Increases in steady-state mRNA levels for all basement membrane components in the heart and vasculature peaked before maximal cardiac hypertrophy (5 days). These studies indicate that alterations in basement membrane component deposition in the hypertrophied vasculature occur at both transcriptional and translational levels and suggest that the cell attachment glycoproteins fibronectin and laminin may be important factors in the vascular response to elevated transmural pressure.


This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. K. Belknap, M. C. M. Weiser-Evans, S. S. Grieshaber, R. A. Majack, and K. R. Stenmark
Relationship between Perlecan and Tropoelastin Gene Expression and Cell Replication in the Developing Rat Pulmonary Vasculature
Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 24 - 34.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. J. Heller, J. A. Opsahl, S. E. Wernsing, R. Saxena, and S. A. Katz
Myocardial and plasma renin-angiotensinogen dynamics during pressure-induced cardiac hypertrophy
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R849 - R856.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. C. Parker, E. C. Breen, and J. B. West
High vascular and airway pressures increase interstitial protein mRNA expression in isolated rat lungs
J Appl Physiol, November 1, 1997; 83(5): 1697 - 1705.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. L. Clements, A. J. Banes, and J. E. Faber
Effect of Mechanical Loading on Vascular {alpha}1D- and {alpha}1B-Adrenergic Receptor Expression
Hypertension, May 1, 1997; 29(5): 1156 - 1164.
[Abstract] [Full Text]